Viewing Study NCT06337318


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2026-03-05 @ 11:18 PM
Study NCT ID: NCT06337318
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2024-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Classic Follicular Lymphoma View
None Follicular Lymphoma With Unusual Cytological Features View
Keywords: